vs
Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and STRATASYS LTD. (SSYS). Click either name above to swap in a different company.
HUTCHMED (China) Ltd is the larger business by last-quarter revenue ($270.8M vs $137.0M, roughly 2.0× STRATASYS LTD.). HUTCHMED (China) Ltd runs the higher net margin — 0.7% vs -40.6%, a 41.3% gap on every dollar of revenue. On growth, STRATASYS LTD. posted the faster year-over-year revenue change (-2.2% vs -16.5%). HUTCHMED (China) Ltd produced more free cash flow last quarter ($3.4M vs $2.5M).
HUTCHMED (China) LtdHCMEarnings & Financial Report
HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.
Stratasys, Ltd. is an American-Israeli manufacturer of 3D printers, software, and materials for polymer additive manufacturing as well as 3D-printed parts on-demand. The company is incorporated in Israel. Engineers use Stratasys systems to model complex geometries in a wide range of polymer materials, including: ABS, polyphenylsulfone (PPSF), polycarbonate (PC), polyetherimide and Nylon 12.
HCM vs SSYS — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $270.8M | $137.0M |
| Net Profit | $2.0M | $-55.6M |
| Gross Margin | 37.7% | 41.0% |
| Operating Margin | -13.2% | -16.6% |
| Net Margin | 0.7% | -40.6% |
| Revenue YoY | -16.5% | -2.2% |
| Net Profit YoY | -83.6% | -109.0% |
| EPS (diluted) | $0.00 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $270.8M | — | ||
| Q3 25 | — | $137.0M | ||
| Q2 25 | $277.7M | $138.1M | ||
| Q1 25 | $324.5M | $136.0M | ||
| Q3 24 | — | $140.0M | ||
| Q2 24 | $305.7M | $138.0M | ||
| Q1 24 | — | $144.1M | ||
| Q3 23 | — | $162.1M |
| Q4 25 | $2.0M | — | ||
| Q3 25 | — | $-55.6M | ||
| Q2 25 | $455.0M | $-16.7M | ||
| Q1 25 | $11.9M | $-13.1M | ||
| Q3 24 | — | $-26.6M | ||
| Q2 24 | $25.8M | $-25.7M | ||
| Q1 24 | — | $-26.0M | ||
| Q3 23 | — | $-47.3M |
| Q4 25 | 37.7% | — | ||
| Q3 25 | — | 41.0% | ||
| Q2 25 | 0.1% | 43.1% | ||
| Q1 25 | 48.0% | 44.3% | ||
| Q3 24 | — | 44.8% | ||
| Q2 24 | 41.1% | 43.8% | ||
| Q1 24 | — | 44.4% | ||
| Q3 23 | — | 40.5% |
| Q4 25 | -13.2% | — | ||
| Q3 25 | — | -16.6% | ||
| Q2 25 | -1.3% | -12.0% | ||
| Q1 25 | -5.0% | -9.1% | ||
| Q3 24 | — | -18.2% | ||
| Q2 24 | -9.0% | -18.9% | ||
| Q1 24 | — | -17.0% | ||
| Q3 23 | — | -26.4% |
| Q4 25 | 0.7% | — | ||
| Q3 25 | — | -40.6% | ||
| Q2 25 | 163.8% | -12.1% | ||
| Q1 25 | 3.7% | -9.6% | ||
| Q3 24 | — | -19.0% | ||
| Q2 24 | 8.4% | -18.6% | ||
| Q1 24 | — | -18.0% | ||
| Q3 23 | — | -29.2% |
| Q4 25 | $0.00 | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $0.52 | — | ||
| Q1 25 | $0.01 | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $0.03 | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | $-0.68 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.4B | $71.5M |
| Total DebtLower is stronger | $93.2M | — |
| Stockholders' EquityBook value | $1.2B | $852.5M |
| Total Assets | $1.8B | $1.1B |
| Debt / EquityLower = less leverage | 0.08× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.4B | — | ||
| Q3 25 | — | $71.5M | ||
| Q2 25 | $1.4B | $71.1M | ||
| Q1 25 | $836.1M | $70.1M | ||
| Q3 24 | — | $64.0M | ||
| Q2 24 | $802.5M | $70.9M | ||
| Q1 24 | — | $91.1M | ||
| Q3 23 | — | $104.6M |
| Q4 25 | $93.2M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $93.4M | — | ||
| Q1 25 | $82.8M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $82.1M | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — |
| Q4 25 | $1.2B | — | ||
| Q3 25 | — | $852.5M | ||
| Q2 25 | $1.2B | $902.4M | ||
| Q1 25 | $759.9M | $784.8M | ||
| Q3 24 | — | $831.8M | ||
| Q2 24 | $740.1M | $850.5M | ||
| Q1 24 | — | $866.1M | ||
| Q3 23 | — | $883.1M |
| Q4 25 | $1.8B | — | ||
| Q3 25 | — | $1.1B | ||
| Q2 25 | $1.8B | $1.1B | ||
| Q1 25 | $1.3B | $1.0B | ||
| Q3 24 | — | $1.1B | ||
| Q2 24 | $1.3B | $1.1B | ||
| Q1 24 | — | $1.1B | ||
| Q3 23 | — | $1.2B |
| Q4 25 | 0.08× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.08× | — | ||
| Q1 25 | 0.11× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.11× | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.2M | $6.9M |
| Free Cash FlowOCF − Capex | $3.4M | $2.5M |
| FCF MarginFCF / Revenue | 1.2% | 1.8% |
| Capex IntensityCapex / Revenue | 1.8% | 3.2% |
| Cash ConversionOCF / Net Profit | 4.21× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-96.2M | $-11.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.2M | — | ||
| Q3 25 | — | $6.9M | ||
| Q2 25 | $-72.9M | $-1.1M | ||
| Q1 25 | $40.3M | $4.5M | ||
| Q3 24 | — | $-4.5M | ||
| Q2 24 | $-39.8M | $-2.4M | ||
| Q1 24 | — | $7.3M | ||
| Q3 23 | — | $-12.7M |
| Q4 25 | $3.4M | — | ||
| Q3 25 | — | $2.5M | ||
| Q2 25 | $-82.2M | $-8.4M | ||
| Q1 25 | $32.5M | $789.0K | ||
| Q3 24 | — | $-6.3M | ||
| Q2 24 | $-49.9M | $-4.9M | ||
| Q1 24 | — | $5.0M | ||
| Q3 23 | — | $-15.0M |
| Q4 25 | 1.2% | — | ||
| Q3 25 | — | 1.8% | ||
| Q2 25 | -29.6% | -6.1% | ||
| Q1 25 | 10.0% | 0.6% | ||
| Q3 24 | — | -4.5% | ||
| Q2 24 | -16.3% | -3.6% | ||
| Q1 24 | — | 3.5% | ||
| Q3 23 | — | -9.3% |
| Q4 25 | 1.8% | — | ||
| Q3 25 | — | 3.2% | ||
| Q2 25 | 3.3% | 5.3% | ||
| Q1 25 | 2.4% | 2.8% | ||
| Q3 24 | — | 1.3% | ||
| Q2 24 | 3.3% | 1.8% | ||
| Q1 24 | — | 1.6% | ||
| Q3 23 | — | 1.4% |
| Q4 25 | 4.21× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -0.16× | — | ||
| Q1 25 | 3.38× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -1.54× | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
